. Schematic diagram for the preparation of clofazimine nanoparticles through the process of flash nanoprecipitation adapted from reference 18.
Mechanistic description of the flash nanoprecipitation (FNP) process
In FNP, hydrophobic compound(s) (clofazimine) and amphiphilic stabilizers (lecithin or zein/casein) are dissolved in a water-miscible organic solvent such as tetrahydrofuran or dimethyl sulfoxide. This 'solvent stream' is then rapidly mixed with an 'anti-solvent stream,' usually water, in either a confined impinging jet mixer or multi-inlet vortex mixer.
Homogeneity is achieved on the order of 5-10 milliseconds via turbulent mixing. Upon mixing, the hydrophobic compound is driven to supersaturation in the mixed solvent environment and begins to precipitate, leading to the nucleation and growth of the nanoparticle core. Diffusionlimited aggregation (DLA) follows. Hydrophobic moieties on the amphiphilic stabilizer adsorb onto the growing nanoparticle core, leading to surface protection that halts further particle growth and results in stable core-shell nanoparticles. 
Equilibrium solubility of clofazimine in lipids
Clofazimine was weighed into glass vials containing tricaprylin, triolein, caprylic acid and oleic acid until excess precipitated drug was seen. The glass vials were placed on a shaker in an incubator at 37 °C for up to 96 hrs. Samples were removed from the incubator at specified time points (3 hrs, 24 hrs and 96 hrs) and ultracentrifuged at 108,726 × g for 30 mins. About 20 mg of the supernatant were transferred into separate glass vials and stored at -20 °C until further analysis. Tetrahydrofuran/methanol (50:50 v/v) was added to the supernatant and samples were diluted in mobile phase (26:74 v/v 0.25 M sodium acetate trihydrate pH 3.3/methanol) prior to HPLC assay using methods detailed in the main manuscript.
